[go: up one dir, main page]

CN101991877B - Preparation method of a three-phase CaP-glass coating/porous Al2O3 scaffold biocomposite - Google Patents

Preparation method of a three-phase CaP-glass coating/porous Al2O3 scaffold biocomposite Download PDF

Info

Publication number
CN101991877B
CN101991877B CN2010105319053A CN201010531905A CN101991877B CN 101991877 B CN101991877 B CN 101991877B CN 2010105319053 A CN2010105319053 A CN 2010105319053A CN 201010531905 A CN201010531905 A CN 201010531905A CN 101991877 B CN101991877 B CN 101991877B
Authority
CN
China
Prior art keywords
porous
coating
glass
phase
scaffold
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2010105319053A
Other languages
Chinese (zh)
Other versions
CN101991877A (en
Inventor
王莉丽
王秀峰
于成龙
江红涛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shaanxi University of Science and Technology
Original Assignee
Shaanxi University of Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shaanxi University of Science and Technology filed Critical Shaanxi University of Science and Technology
Priority to CN2010105319053A priority Critical patent/CN101991877B/en
Publication of CN101991877A publication Critical patent/CN101991877A/en
Application granted granted Critical
Publication of CN101991877B publication Critical patent/CN101991877B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Materials For Medical Uses (AREA)
  • Glass Compositions (AREA)

Abstract

本发明提供了一种三相CaP-玻璃涂层/多孔Al2O3支架生物复合材料的制备方法,属于生物医用材料制备技术领域。在多孔Al2O3支架上涂敷由HA和磷酸盐为基体的生物玻璃组成的复合涂层,获得良好的生物性能和机械性能的组合。将HA粉体和不同组成的生物玻璃粉末以不同比例混合,制成料浆涂敷在多孔Al2O3支架上,在800℃的空气中热处理2h。涂层相出现了羟基磷灰石(HA)、磷酸三钙(TCP)和磷酸氢钙(DCP)主晶相,形成了三相CaP-玻璃涂层。这种三相CaP-玻璃涂层密实,均匀,紧密地附着在多孔Al2O3支架上。结合强度最高可达到50MPa,是纯HA涂层结合强度的两倍以上。造骨细胞在这种涂敷有三相CaP-玻璃涂层的多孔Al2O3支架上生长良好,细胞积极地穿过涂层向多孔之架内部扩散。The invention provides a method for preparing a three-phase CaP-glass coating/porous Al 2 O 3 scaffold biocomposite material, which belongs to the technical field of biomedical material preparation. A composite coating consisting of HA and phosphate -based bioglass was applied on porous Al2O3 scaffolds to obtain a good combination of biological and mechanical properties. HA powder and bioglass powder of different compositions were mixed in different proportions to make a slurry coated on a porous Al 2 O 3 support, and heat treated in air at 800°C for 2h. Hydroxyapatite (HA), tricalcium phosphate (TCP) and hydrogen calcium phosphate (DCP) main crystal phases appeared in the coating phase, forming a three-phase CaP-glass coating. This three-phase CaP-glass coating is dense , uniform, and tightly attached to the porous Al2O3 scaffold. The bonding strength can reach up to 50MPa, which is more than twice the bonding strength of pure HA coating. Osteoblasts grew well on this porous Al 2 O 3 scaffold coated with a three-phase CaP-glass coating, and the cells actively diffused through the coating to the interior of the porous scaffold.

Description

一种三相CaP-玻璃涂层/多孔Al2O3支架生物复合材料的制备方法Preparation method of a three-phase CaP-glass coating/porous Al2O3 scaffold biocomposite

技术领域 technical field

本发明属于生物医用材料制备技术领域,涉及是一种三相CaP-玻璃涂层/多孔Al2O3支架生物复合材料的制备方法。The invention belongs to the technical field of preparation of biomedical materials, and relates to a preparation method of a three-phase CaP-glass coating/porous Al 2 O 3 support biocomposite material.

背景技术 Background technique

羟基磷灰石(hydroxyapatite,HA),是人体自然骨的主要成分(60~70%),具有极好的生物活性和骨组织生长的引导性。因此,在骨替代方面引起了人们极大的兴趣。临床试验表明HA具有直接与骨结合的能力和完全的骨传导性。然而,较差的机械性能,诸如强度和断裂韧性,限制了它在硬组织替换方面的应用。Hydroxyapatite (hydroxyapatite, HA) is the main component (60-70%) of the human body's natural bone, and has excellent biological activity and guidance for bone tissue growth. Therefore, it has aroused great interest in bone replacement. Clinical trials have shown that HA has the ability to directly combine with bone and complete osteoconductivity. However, poor mechanical properties, such as strength and fracture toughness, limit its application in hard tissue replacement.

一种涂层-基体系统,例如以ZrO2,Al2O3,Ti及其合金为基体,以HA作为涂层,可以获得机械性能和生物性能的良好结合。研究表明,在多孔Al2O3支架上涂敷HA涂层,可以得到20~30μm厚度的涂层,然而,涂层的形态是微孔的,结合强度小于25MPa。如果涂层和基体之间的结合力很差,就会使得硬组织替换变得很困难,而且,和真正的人骨相比,烧结HA的溶解速率和生物活性都较差。A coating-substrate system, such as ZrO 2 , Al 2 O 3 , Ti and their alloys as the substrate, and HA as the coating, can obtain a good combination of mechanical properties and biological properties. Studies have shown that coating HA coatings on porous Al 2 O 3 scaffolds can obtain coatings with a thickness of 20-30 μm, however, the morphology of the coatings is microporous, and the bonding strength is less than 25 MPa. Hard tissue replacement becomes difficult if the bonding force between the coating and the substrate is poor, and the dissolution rate and bioactivity of sintered HA are poor compared with real human bone.

发明内容 Contents of the invention

本发明所要解决的技术问题是提供一种三相CaP-玻璃涂层/多孔Al2O3支架生物复合材料的制备方法,其中,三相CaP-玻璃涂层密实,均匀,紧密地附着在多孔Al2O3支架上,涂层与支架之间的结合强度最高可达到50MPa,是纯HA涂层结合强度的两倍以上。The technical problem to be solved by the present invention is to provide a preparation method of a three-phase CaP-glass coating/porous Al2O3 scaffold biocomposite material, wherein, the three-phase CaP-glass coating is compact, uniform , and tightly attached to the porous On the Al 2 O 3 stent, the bonding strength between the coating and the stent can reach up to 50MPa, which is more than twice the bonding strength of the pure HA coating.

为实现上述目的,本发明还提供了一种三相CaP-玻璃涂层/多孔Al2O3支架生物复合材料的制备方法,包括以下步骤:In order to achieve the above object, the present invention also provides a kind of three-phase CaP-glass coating/porous Al2O3 preparation method of scaffold biocomposite material, comprising the following steps:

步骤一:三相玻璃的制备:按照组成式为xCaO·(0.55-x)Na2O·0.45P2O5,其中x取0.1~0.5,称取P2O5,NaH2PO4和CaCO3,在1100~1250℃烧结1h进行熔化;Step 1: Preparation of triple-phase glass: according to the composition formula xCaO·(0.55-x)Na 2 O·0.45P 2 O 5 , where x is 0.1-0.5, weigh P 2 O 5 , NaH 2 PO 4 and CaCO 3. Sinter at 1100-1250°C for 1 hour to melt;

步骤二:将步骤(1)得到的熔融玻璃依次进行淬火、研磨和分筛,得到玻璃粉体;Step 2: sequentially quenching, grinding and sieving the molten glass obtained in step (1) to obtain glass powder;

步骤三:将步骤(2)得到的玻璃粉体和羟基磷灰石混合于乙醇中,球磨24小时,得到混合浆料;Step 3: mixing the glass powder and hydroxyapatite obtained in step (2) in ethanol, and ball milling for 24 hours to obtain a mixed slurry;

步骤四:采用浸渍法制备多孔Al2O3支架,然后在多孔Al2O3支架上涂敷步骤(3)得到的混合料浆,从而制得复合涂层;Step 4: preparing a porous Al 2 O 3 support by dipping method, and then coating the mixed slurry obtained in step (3) on the porous Al 2 O 3 support to obtain a composite coating;

步骤五:待复合涂层干燥后,将多孔Al2O3支架以50℃/min的速率加热到700℃,再以5℃/min的速率加热到800℃,保温2h,随后以1℃/min的速率冷却到室温。Step 5: After the composite coating is dried, heat the porous Al 2 O 3 stent to 700°C at a rate of 50°C/min, then to 800°C at a rate of 5°C/min, hold for 2 hours, and then heat at 1°C/min Cool down to room temperature at a rate of min.

本发明三相CaP-玻璃涂层/多孔Al2O3支架生物复合材料的制备方法至少具有以下优点:本发明将HA粉体和生物玻璃粉末混合,制成料浆,然后涂敷在多孔Al2O3支架上,在800℃于空气中热处理2h。涂层相出现了羟基磷灰石(HA)、磷酸三钙(TCP)和磷酸氢钙(DCP)主晶相,形成了三相CaP-玻璃涂层。而这种三相CaP-玻璃涂层密实,均匀,紧密地附着在多孔Al2O3支架上,涂层与支架之间的结合强度最高可达到50MPa,是纯HA涂层结合强度的两倍以上。The preparation method of the three-phase CaP-glass coating/porous Al 2 O 3 scaffold bio-composite material of the present invention has at least the following advantages: the present invention mixes HA powder and bio-glass powder to make a slurry, and then coats it on the porous Al 2 O 3 support, heat treatment in air at 800 ℃ for 2h. Hydroxyapatite (HA), tricalcium phosphate (TCP) and hydrogen calcium phosphate (DCP) main crystal phases appeared in the coating phase, forming a three-phase CaP-glass coating. And this three-phase CaP-glass coating is dense, uniform, and tightly attached to the porous Al2O3 support, and the bonding strength between the coating and the support can reach up to 50MPa , which is twice the bonding strength of the pure HA coating. above.

附图说明 Description of drawings

图1是在800℃热处理2小时,CaO含量为30mol%的玻璃不同添加量制得的复合涂层的XRD图谱。Fig. 1 is the XRD patterns of composite coatings prepared by heat treatment at 800°C for 2 hours and with different additions of glass with a CaO content of 30 mol%.

具体实施方式 Detailed ways

本发明三相CaP-玻璃涂层/多孔Al2O3支架生物复合材料的制备方法包括以下步骤:The preparation method of the three-phase CaP-glass coating/porous Al2O3 support biocomposite material of the present invention comprises the following steps :

实施例1Example 1

(1)三相玻璃的制备:按照组成式为xCaO·(0.55-x)Na2O·0.45P2O5,其中x取0.1,称取P2O5,NaH2PO4和CaCO3,在1100℃烧结1h进行熔化;(1) Preparation of triple-phase glass: according to the composition formula xCaO·(0.55-x)Na 2 O·0.45P 2 O 5 , where x is 0.1, weigh P 2 O 5 , NaH 2 PO 4 and CaCO 3 , Sinter at 1100°C for 1 hour to melt;

(2)将步骤(1)得到的熔融的玻璃依次进行淬火、研磨和分筛,得到颗粒尺寸小于20μm的玻璃粉体;(2) quenching, grinding and sieving the molten glass obtained in step (1) successively to obtain glass powder with a particle size less than 20 μm;

(3)将步骤(2)得到的玻璃粉体和羟基磷灰石(hydroxyapatite,HA)混合于乙醇中,球磨24小时,得到混合浆料,其中,玻璃粉体占玻璃粉体和羟基磷灰石总质量的5%;(3) The glass powder obtained in step (2) and hydroxyapatite (hydroxyapatite, HA) were mixed in ethanol, and ball milled for 24 hours to obtain a mixed slurry, wherein the glass powder accounted for the glass powder and hydroxyapatite 5% of the total mass of stone;

(4)采用浸渍法制备多孔Al2O3支架,然后在多孔Al2O3支架上采用浸渍-旋转工艺涂敷步骤(3)得到的混合料浆,从而制得复合涂层;(4) Prepare porous Al 2 O 3 support by dipping method, and then apply the mixed slurry obtained in step (3) on the porous Al 2 O 3 support by dipping-spinning process, so as to obtain a composite coating;

(5)待复合涂层干燥后,将多孔Al2O3支架以10℃/min的速率加热到700℃,再以5℃/min的速率加热到800℃,保温2h,随后以1℃/min的速率冷却到室温。(5) After the composite coating is dried, the porous Al 2 O 3 scaffold is heated to 700°C at a rate of 10°C/min, then heated to 800°C at a rate of 5°C/min, kept for 2 hours, and then heated at a rate of 1°C/min Cool down to room temperature at a rate of min.

实施例2Example 2

(1)三相玻璃的制备:按照组成式为xCaO·(0.55-x)Na2O·0.45P2O5,其中x取0.2,称取P2O5,NaH2PO4和CaCO3,在1250℃烧结1h进行熔化;(1) Preparation of triple-phase glass: according to the composition formula xCaO·(0.55-x)Na 2 O·0.45P 2 O 5 , where x is 0.2, weigh P 2 O 5 , NaH 2 PO 4 and CaCO 3 , Sinter at 1250°C for 1 hour to melt;

(2)将步骤(1)得到的熔融的玻璃依次进行淬火、研磨和分筛,得到颗粒尺寸小于20μm的玻璃粉体;(2) quenching, grinding and sieving the molten glass obtained in step (1) successively to obtain glass powder with a particle size less than 20 μm;

(3)将步骤(2)得到的玻璃粉体和羟基磷灰石(hydroxyapatite,HA)混合于乙醇中,球磨24小时,得到混合浆料,其中,玻璃粉体占玻璃粉体和羟基磷灰石总质量的50%;(3) The glass powder obtained in step (2) and hydroxyapatite (hydroxyapatite, HA) were mixed in ethanol, and ball milled for 24 hours to obtain a mixed slurry, wherein the glass powder accounted for the glass powder and hydroxyapatite 50% of the total mass of stone;

(4)采用浸渍法制备多孔Al2O3支架,然后在多孔Al2O3支架上采用浸渍-旋转工艺涂敷步骤(3)得到的混合料浆,从而制得复合涂层;(4) Prepare porous Al 2 O 3 support by dipping method, and then apply the mixed slurry obtained in step (3) on the porous Al 2 O 3 support by dipping-spinning process, so as to obtain a composite coating;

(5)待复合涂层干燥后,将多孔Al2O3支架以10℃/min的速率加热到700℃,再以5℃/min的速率加热到800℃,保温2h,随后以1℃/min的速率冷却到室温。(5) After the composite coating is dried, the porous Al 2 O 3 scaffold is heated to 700°C at a rate of 10°C/min, then heated to 800°C at a rate of 5°C/min, kept for 2 hours, and then heated at a rate of 1°C/min Cool down to room temperature at a rate of min.

实施例3Example 3

(1)三相玻璃的制备:按照组成式为xCaO·(0.55-x)Na2O·0.45P2O5,其中x取0.3,称取P2O5,NaH2PO4和CaCO3,在1150℃烧结1h进行熔化;(1) Preparation of triple-phase glass: according to the composition formula xCaO·(0.55-x)Na 2 O·0.45P 2 O 5 , where x is 0.3, weigh P 2 O 5 , NaH 2 PO 4 and CaCO 3 , Sinter at 1150°C for 1 hour to melt;

(2)将步骤(1)得到的熔融的玻璃依次进行淬火、研磨和分筛,得到颗粒尺寸小于20μm的玻璃粉体;(2) quenching, grinding and sieving the molten glass obtained in step (1) successively to obtain glass powder with a particle size less than 20 μm;

(3)将步骤(2)得到的玻璃粉体和羟基磷灰石(hydroxyapatite,HA)混合于乙醇中,球磨24小时,得到混合浆料,其中,玻璃粉体占玻璃粉体和羟基磷灰石总质量的15%;(3) The glass powder obtained in step (2) and hydroxyapatite (hydroxyapatite, HA) were mixed in ethanol, and ball milled for 24 hours to obtain a mixed slurry, wherein the glass powder accounted for the glass powder and hydroxyapatite 15% of the total mass of stone;

(4)采用浸渍法制备多孔Al2O3支架,然后在多孔Al2O3支架上采用浸渍-旋转工艺涂敷步骤(3)得到的混合料浆,从而制得复合涂层;(4) Prepare porous Al 2 O 3 support by dipping method, and then apply the mixed slurry obtained in step (3) on the porous Al 2 O 3 support by dipping-spinning process, so as to obtain a composite coating;

(5)待复合涂层干燥后,将多孔Al2O3支架以10℃/min的速率加热到700℃,再以5℃/min的速率加热到800℃,保温2h,随后以1℃/min的速率冷却到室温。(5) After the composite coating is dried, the porous Al 2 O 3 scaffold is heated to 700°C at a rate of 10°C/min, then heated to 800°C at a rate of 5°C/min, kept for 2 hours, and then heated at a rate of 1°C/min Cool down to room temperature at a rate of min.

实施例4Example 4

(1)三相玻璃的制备:按照组成式为xCaO·(0.55-x)Na2O·0.45P2O5,其中x取0.5,称取P2O5,NaH2PO4和CaCO3,在1200℃烧结1h进行熔化;(1) Preparation of triple-phase glass: according to the composition formula xCaO·(0.55-x)Na 2 O·0.45P 2 O 5 , where x is 0.5, weigh P 2 O 5 , NaH 2 PO 4 and CaCO 3 , Sinter at 1200°C for 1 hour to melt;

(2)将步骤(1)得到的熔融的玻璃依次进行淬火、研磨和分筛,得到颗粒尺寸小于20μm的玻璃粉体;(2) quenching, grinding and sieving the molten glass obtained in step (1) successively to obtain glass powder with a particle size less than 20 μm;

(3)将步骤(2)得到的玻璃粉体和羟基磷灰石(hydroxyapatite,HA)混合于乙醇中,球磨24小时,得到混合浆料,其中,玻璃粉体占玻璃粉体和羟基磷灰石总质量的35%;(3) The glass powder obtained in step (2) and hydroxyapatite (hydroxyapatite, HA) were mixed in ethanol, and ball milled for 24 hours to obtain a mixed slurry, wherein the glass powder accounted for the glass powder and hydroxyapatite 35% of the total mass of stone;

(4)采用浸渍法制备多孔Al2O3支架,然后在多孔Al2O3支架上采用浸渍-旋转工艺涂敷步骤(3)得到的混合料浆,从而制得复合涂层;(4) Prepare porous Al 2 O 3 support by dipping method, and then apply the mixed slurry obtained in step (3) on the porous Al 2 O 3 support by dipping-spinning process, so as to obtain a composite coating;

(5)待复合涂层干燥后,将多孔Al2O3支架以10℃/min的速率加热到700℃,再以5℃/min的速率加热到800℃,保温2h,随后以1℃/min的速率冷却到室温。(5) After the composite coating is dried, the porous Al 2 O 3 scaffold is heated to 700°C at a rate of 10°C/min, then heated to 800°C at a rate of 5°C/min, kept for 2 hours, and then heated at a rate of 1°C/min Cool down to room temperature at a rate of min.

本发明同已有产品相比具有以下优点:Compared with existing products, the present invention has the following advantages:

1)本发明得到的三相CaP-玻璃涂层和多孔Al2O3支架之间结合紧密,孔隙均匀,没有出现闭塞的变形孔;涂覆在支架上的玻璃涂层厚度约为30μm,没有出现分层和裂纹,表明它们之间结合完美;而传统的单一HA涂层,由于其本身是微孔的,因此,和多孔Al2O3支架之间看不到紧密的结合形态,导致结合强度很低,一般不超过25MPa;1) The three-phase CaP-glass coating obtained in the present invention is closely combined with the porous Al 2 O 3 support, the pores are uniform, and there is no blocked deformation hole; the thickness of the glass coating coated on the support is about 30 μm, and there is no Delamination and cracks appear, indicating that they are perfectly bonded; while the traditional single HA coating, because it is microporous, cannot see a tight bond with the porous Al 2 O 3 scaffold, resulting in a The strength is very low, generally no more than 25MPa;

2)玻璃添加量为35wt%,CaO含量小于30mol%的三相CaP-玻璃涂层与多孔Al2O3支架的结合强度最大,达到了50MPa,几乎是单一HA涂层的两倍(小于25MPa)。如此大的结合力是因为玻璃的加入,涂层更加密集,与基体的结合更加紧密;2) The three-phase CaP-glass coating with a glass addition of 35wt% and a CaO content of less than 30mol % has the highest bonding strength to the porous Al2O3 scaffold, reaching 50MPa, almost twice that of a single HA coating (less than 25MPa ). Such a large bonding force is due to the addition of glass, the coating is denser, and the combination with the substrate is tighter;

3)请参阅图1所示,本发明得到的三相CaP-玻璃涂层的物相分析中出现了HA,TCP,DCP主晶相,它们的化学成分很相似,使得三相CaP-玻璃涂层较单一的HA涂层生物活性大大增强;3) Please refer to shown in Fig. 1, HA, TCP, and DCP main crystal phases appear in the phase analysis of the three-phase CaP-glass coating that the present invention obtains, and their chemical composition is very similar, makes three-phase CaP-glass coating The biological activity of the layer is greatly enhanced compared with the single HA coating;

4)单一HA涂层的烧结温度较高,一般大于1200℃,而本发明得到的三相CaP-玻璃涂层熔点很低,800℃左右,大大的降低了烧结温度,改善了涂层的形态;4) The sintering temperature of a single HA coating is relatively high, generally greater than 1200°C, while the melting point of the three-phase CaP-glass coating obtained in the present invention is very low, about 800°C, which greatly reduces the sintering temperature and improves the morphology of the coating ;

5)本发明得出了HA,TCP,DCP主晶相随玻璃的添加量和玻璃中CaO含量的变化规律,即增加玻璃中CaO含量,三相CaP-玻璃涂层中HA相的含量就增加;增加玻璃的添加量,HA相的含量在减小。这样就可以控制三相CaP-玻璃涂层中的物相含量;5) The present invention has obtained HA, TCP, the change law of the main crystal phase of DCP with the addition amount of glass and the CaO content in the glass, promptly increases CaO content in the glass, the content of HA phase just increases in the three-phase CaP-glass coating ; Increase the amount of glass added, the content of HA phase is decreasing. This allows control of the phase content in the three-phase CaP-glass coating;

6)本发明得出了三相CaP-玻璃涂层中三个主晶相出现的原因,即随着玻璃的熔化和缓慢的冷却,发生了晶化,形成了微晶玻璃;在熔化-冷却的过程中,形成了TCP和DCP相;这三个相的含量的不同取决于玻璃的组成;6) The present invention has drawn the reason that three main crystal phases appear in the three-phase CaP-glass coating, promptly along with the fusing of glass and slow cooling, crystallization has taken place, has formed glass-ceramic; During the process, TCP and DCP phases are formed; the content of these three phases depends on the composition of the glass;

7)单一玻璃涂层在烧成的过程中会产生许多其它的钙磷相,如Ca(PO3)2,4CaO·3P2O5,NaCaPO4,DCP和TCP,但是没有HA相,生物活性大大降低了。然而,本发明得到的三相CaP-玻璃涂层在烧成的过程中只有DCP,TCP,HA相,这些相都具有生物活性和生物相容性;7) A single glass coating will produce many other calcium phosphorus phases during the firing process, such as Ca(PO 3 ) 2 , 4CaO·3P 2 O 5 , NaCaPO 4 , DCP and TCP, but there is no HA phase, biological activity greatly reduced. However, the three-phase CaP-glass coating obtained by the present invention has only DCP, TCP, and HA phases during firing, and these phases all have bioactivity and biocompatibility;

8)单一的玻璃涂层涂敷在多孔Al2O3支架上,由于热膨胀系数的不匹配,出现了严重的裂纹和分层,然而本发明得到的三相CaP-玻璃涂层与多孔Al2O3支架结合完美。8) A single glass coating is coated on a porous Al 2 O 3 support, due to the mismatch of thermal expansion coefficients, severe cracks and delamination have occurred, but the three-phase CaP-glass coating obtained by the present invention is compatible with porous Al 2 O 3 brackets combine perfectly.

以上所述仅为本发明的一种实施方式,不是全部或唯一的实施方式,本领域普通技术人员通过阅读本发明说明书而对本发明技术方案采取的任何等效的变换,均为本发明的权利要求所涵盖。The above is only one embodiment of the present invention, not all or the only embodiment. Any equivalent transformation of the technical solution of the present invention adopted by those of ordinary skill in the art by reading the description of the present invention is the right of the present invention. covered by the requirements.

Claims (1)

1.一种三相CaP-玻璃涂层/多孔Al2O3支架生物复合材料的制备方法,其特征在于:包括以下步骤:1. a kind of three-phase CaP-glass coating/porous Al 2 O The preparation method of support biocomposite material, it is characterized in that: comprise the following steps: 步骤一:三相玻璃的制备:按照组成式为xCaO·(0.55-x)Na2O·0.45P2O5,其中x取0.1~0.5,称取P2O5,NaH2PO4和CaCO3,在1100~1250℃烧结1h进行熔化;Step 1: Preparation of triple-phase glass: according to the composition formula xCaO·(0.55-x)Na 2 O·0.45P 2 O 5 , where x is 0.1-0.5, weigh P 2 O 5 , NaH 2 PO 4 and CaCO 3. Sinter at 1100-1250°C for 1 hour to melt; 步骤二:将步骤(1)得到的熔融玻璃依次进行淬火、研磨和分筛,得到玻璃粉体;Step 2: sequentially quenching, grinding and sieving the molten glass obtained in step (1) to obtain glass powder; 步骤三:将步骤(2)得到的玻璃粉体和羟基磷灰石混合于乙醇中,球磨24小时,得到混合浆料,其中,玻璃粉体占玻璃粉体和羟基磷灰石总质量的5~50%;Step 3: Mix the glass powder and hydroxyapatite obtained in step (2) in ethanol, and ball mill for 24 hours to obtain a mixed slurry, wherein the glass powder accounts for 5% of the total mass of the glass powder and hydroxyapatite ~50%; 步骤四:采用浸渍法制备多孔Al2O3支架,然后在多孔Al2O3支架上涂敷步骤(3)得到的混合料浆,从而制得复合涂层;Step 4: preparing a porous Al 2 O 3 support by dipping method, and then coating the mixed slurry obtained in step (3) on the porous Al 2 O 3 support to obtain a composite coating; 步骤五:待复合涂层干燥后,将多孔Al2O3支架以50℃/min的速率加热到700℃,再以5℃/min的速率加热到800℃,保温2h,随后以1℃/min的速率冷却到室温。Step 5: After the composite coating is dried, heat the porous Al 2 O 3 stent to 700°C at a rate of 50°C/min, then to 800°C at a rate of 5°C/min, hold for 2 hours, and then heat at 1°C/min Cool down to room temperature at a rate of min.
CN2010105319053A 2010-11-02 2010-11-02 Preparation method of a three-phase CaP-glass coating/porous Al2O3 scaffold biocomposite Expired - Fee Related CN101991877B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010105319053A CN101991877B (en) 2010-11-02 2010-11-02 Preparation method of a three-phase CaP-glass coating/porous Al2O3 scaffold biocomposite

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010105319053A CN101991877B (en) 2010-11-02 2010-11-02 Preparation method of a three-phase CaP-glass coating/porous Al2O3 scaffold biocomposite

Publications (2)

Publication Number Publication Date
CN101991877A CN101991877A (en) 2011-03-30
CN101991877B true CN101991877B (en) 2012-07-25

Family

ID=43782954

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010105319053A Expired - Fee Related CN101991877B (en) 2010-11-02 2010-11-02 Preparation method of a three-phase CaP-glass coating/porous Al2O3 scaffold biocomposite

Country Status (1)

Country Link
CN (1) CN101991877B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9222842B2 (en) * 2013-01-07 2015-12-29 Kla-Tencor Corporation High temperature sensor wafer for in-situ measurements in active plasma
CN108395236A (en) * 2018-01-25 2018-08-14 合肥中科富华新材料有限公司 A kind of preparation method and applications of bioceramic

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN2067157U (en) * 1990-06-01 1990-12-12 中国科学院上海硅酸盐研究所 Surface active alumina biological ceramic implant
CN1080627A (en) * 1992-06-29 1994-01-12 国家建筑材料工业局山东工业陶瓷研究设计院 Biological active incline ceramic material
CN1397518A (en) * 2002-08-28 2003-02-19 中国科学院长春应用化学研究所 Process for preparing nano-class hydroxyphosphorite/alumina bioceramics

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7740481B2 (en) * 2002-06-21 2010-06-22 Politecnico Di Milano Osteointegrative interface for implantable prostheses and a method for the treatment of the osteointegrative interface
FR2938271B1 (en) * 2008-11-13 2011-09-02 Univ Reims Champagne Ardenne PROCESS FOR THE ELECTRODEPOSITION OF PHOSPHOCALCIUM COATINGS ON METALLIC SUBSTRATES, COATINGS OBTAINED AND IMPLANTABLE MATERIALS COMPRISING SUCH COATINGS

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN2067157U (en) * 1990-06-01 1990-12-12 中国科学院上海硅酸盐研究所 Surface active alumina biological ceramic implant
CN1080627A (en) * 1992-06-29 1994-01-12 国家建筑材料工业局山东工业陶瓷研究设计院 Biological active incline ceramic material
CN1397518A (en) * 2002-08-28 2003-02-19 中国科学院长春应用化学研究所 Process for preparing nano-class hydroxyphosphorite/alumina bioceramics

Also Published As

Publication number Publication date
CN101991877A (en) 2011-03-30

Similar Documents

Publication Publication Date Title
Sergi et al. A comprehensive review of bioactive glass coatings: State of the art, challenges and future perspectives
Wu et al. A review of bioactive silicate ceramics
Li et al. Effect of CeO2 and Y2O3 on microstructure, bioactivity and degradability of laser cladding CaO–SiO2 coating on titanium alloy
Bellucci et al. An overview of the effects of thermal processing on bioactive glasses
Vitale-Brovarone et al. Bioactive glass-derived trabecular coating: a smart solution for enhancing osteointegration of prosthetic elements
Karamian et al. Fabrication of hydroxyapatite-baghdadite nanocomposite scaffolds coated by PCL/Bioglass with polyurethane polymeric sponge technique
TWI283657B (en) CaO-SiO2-based bioactive glass and sintered calcium phosphate glass using same
JP2012531377A (en) Multicomponent glass
Zakaria et al. Incorporation of wollastonite bioactive ceramic with titanium for medical applications: An overview
CN108950305A (en) A kind of preparation method of titanium alloy-hydroxy-apatite halite bioceramic porous material
Yi et al. Preparation and in vitro evaluation of plasma-sprayed bioactive akermanite coatings
Hazar Preparation and in vitro bioactivity of CaSiO3 powders
Cannillo et al. In vitro characterisation of plasma-sprayed apatite/wollastonite glass–ceramic biocoatings on titanium alloys
Kasuga et al. Calcium phosphate invert glass-ceramic coatings joined by self-development of compositionally gradient layers on a titanium alloy
Mesquita-Guimarães et al. Bioactive glass coatings
Liu et al. Characterization of plasma sprayed wollastonite powder and coatings
CN102851664B (en) Method for preparing hydroxy apatite biological ceramic coating containing fluorine
Cao et al. An experimental bone defect healing with hydroxyapatite coating plasma sprayed on carbon/carbon composite implants
Braem et al. Biofunctionalization of porous titanium coatings through sol–gel impregnation with a bioactive glass–ceramic
Vyas et al. Microstructural analysis and bioactive response of selectively engineered glass-ceramics in simulated body fluid
CN101991877B (en) Preparation method of a three-phase CaP-glass coating/porous Al2O3 scaffold biocomposite
Wang et al. Microstructure of yttric calcium phosphate bioceramic coatings synthesized by laser cladding
Su et al. In-situ synthesis and characterization of calcium phosphate coatings on rapidly solidified zirconia toughened alumina eutectic bioceramics by laser cladding
Xu et al. Mesoporous calcium silicate and titanium composite scaffolds via 3D-printing for improved properties in bone repair
Jinga et al. Sol–gel-derived mineral scaffolds within SiO 2–P 2 O 5–CaO–MgO–ZnO–CaF 2 system

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20120725

Termination date: 20141102

EXPY Termination of patent right or utility model